SGM
HCAT icon

Skye Global Management’s Health Catalyst HCAT Stock Holding History

Skye Global Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,400
Closed -$253K – 70
2021
Q1 		$253K Sell
5,400
-46,600
-90% -$2.26M ﹤0.01% 61
2020
Q4 		$2.26M Buy
+52,000
New +$1.92M 0.05% 43

Other funds holding HCAT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Skye Global Management's HCAT Position: Q2 2021 in Review

Skye Global Management sold out of Health Catalyst (HCAT) in Q2 2021, closing a stake of 5,400 shares — an estimated $253K sold.

Skye Global Management first reported a position in HCAT in Q4 2020 and held it in 2 quarters. The position peaked at $2.26M in Q4 2020. 198 funds tracked by Wall St. Rank hold HCAT as of Q2 2021.

  • Skye Global Management reported no remaining Health Catalyst position as of Q2 2021 after selling out during the quarter.
  • Skye Global Management sold 5,400 Health Catalyst shares in Q2 2021, an estimated $253K.
  • Skye Global Management first reported a position in Health Catalyst in Q4 2020 and held it in 2 quarters.
  • Skye Global Management's Health Catalyst position peaked at $2.26M in Q4 2020.
  • 198 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2021.

Based on Skye Global Management's 13F filing for Q2 2021, filed 16 Aug 2021.